• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma news

The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Victoria White on +44 (0)1959 563311 or email us.

Industry News

Sanofi makes $9.3b offer to acquire Medivation

Posted on: 28 April 2016

Sanofi has made an unsolicited $9.3 billion offer to acquire Medivation, the maker of prostate cancer drug Xtandi...

Positive topline results from a Phase Ib study of BioChaperone Lispro

Posted on: 28 April 2016

Adocia and Lilly have announced positive topline results from a Phase Ib trial evaluating BioChaperone Lispro, an ultra-rapid formulation of insulin lispro...

Semaglutide reduces the risk of major adverse cardiovascular events in trial

Posted on: 28 April 2016

The double-blinded SUSTAIN6 trial investigated the long-term cardiovascular and other safety outcomes of 0.5 mg and 1.0 mg semaglutide compared with placebo...

Novartis’ Ilaris provides hope for Periodic Fever Syndrome patients

Posted on: 27 April 2016

Novartis announced today that the FDA has granted three breakthrough therapy designations for Ilaris® (canakinumab) to treat rare types of Periodic Fever Syndromes, also known as Hereditary Periodic Fevers.

Teaching machines to make clinical trials more successful

Posted on: 27 April 2016

Researchers at are using so-called "machine learning" technologies to predict whether patients will participate in clinical trials...

NICE recommends heart failure drug Entresto

Posted on: 27 April 2016

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Entresto (sacubitril valsartan) for some people with heart failure...

EC grants marketing authorisation to Lonsurf in mCRC

Posted on: 27 April 2016

The decision from the EC was based on data from the international, double-blind, placebo-controlled Phase III RECOURSE study...

NICE says ‘yes’ to two ovarian cancer drugs, rejects three

Posted on: 27 April 2016

The guidance recommends paclitaxel and PLDH for treating ovarian cancer that has returned after previous chemotherapy treatment...

The global cost of norovirus

Posted on: 26 April 2016

Norovirus results in roughly $4.2 billion in health care costs and $60.3 billion in societal costs annually, a new study has found...

Promising top-line results for AZP-531 in Prader-Willi Syndrome

Posted on: 26 April 2016

Alizé Pharma has announced top-line results of a Phase II clinical trial of AZP-531 in patients with Prader-Willi Syndrome (PWS)...

EC grants marketing authorisation to Lilly’s ixekizumab

Posted on: 26 April 2016

The EC has granted marketing authorisation for Lilly’s ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults...

AstraZeneca and Ironwood sign Zurampic licensing agreement

Posted on: 26 April 2016

Under the terms of the agreement, Ironwood Pharmaceuticals will acquire exclusive US rights to Zurampic from AstraZeneca...

 

Supplier News

3rd Pharmaceutical Traceability Forum to attract expert serialization and packaging professionals from across the nation

Posted on: 29 April 2016

Harmonize serialization plans to achieve compliance. Supply chain stakeholders must take a comprehensive view of their traceability strategy...

Watson-Marlow Fluid Technology Group is the world leader in niche peristaltic pumps and associated fluid path technologies

Posted on: 27 April 2016

Watson-Marlow is the only company in the world able to provide a complete package of fluid path technology expertise to the biotechnology industries...

asepticSU™ single use technology eliminates cleaning validation

Posted on: 27 April 2016

Cleaning validation has been eliminated, traceability simplified and filling accuracy enhanced...

New Watson-Marlow 530 pumps deliver step-change improvements in validated process security for biopharm applications

Posted on: 27 April 2016

Watson-Marlow Fluid Technology Group has introduced its new 530 peristaltic cased pump for upstream and downstream bioprocessing tasks...

Optimizing quality and production with Russell Finex sanitary screener

Posted on: 25 April 2016

When Enzymatic Therapy stopped outsourcing and built its own FDA-approved manufacturing facility, the goal was to improve product quality, streamline production, and ramp up sales growth...

Release of future proofed Artwork Lifecycle Management System by Perigord leads way for Life Science companies

Posted on: 7 April 2016

Perigord has officially launched the latest release of their proprietary innovative software, GLAMS (Global Artwork Management System)...

Black Swan Analysis has added to its Epiomic Epidemiology series of reports with Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026

Posted on: 6 April 2016

Research and Markets has announced the addition of the "Benign Prostatic Hypertrophy Forecast in 17 Major Markets 2016-2026" report to their offering...

Coulter Partners has placed Dr Neil Brewis as Chief Scientific Officer and Michael Davies as VP Protein Science at F-star

Posted on: 6 April 2016

Coulter Partners has placed Dr Neil Brewis as Chief Scientific Officer and Michael Davies as VP Protein Science at F-star...

Future proofing – Part 2. PAT – Real time release testing of tablets

Posted on: 4 April 2016

What requirements need to be met by a tablet testing system to guarantee a successful product release?

Paul Whittles takes the reins at Sirius Analytical!

Posted on: 1 April 2016

Sirius Analytical are pleased to announce that Paul Whittles has been appointed as its new Managing Director...

DiscoverX launches KILR™ assay platform for use in cancer immunotherapy drug development

Posted on: 30 March 2016

DiscoverX Corporation has launched the KILR Retroparticles product line, providing scientists complete flexibility to develop a simple cytotoxicity assay in almost any cell line...

Coulter Partners appoints Laura Esam as London Director

Posted on: 30 March 2016

Global Life Sciences search specialist, Coulter Partners, have appointed Laura Esam as Director in their London office...

 

 

Webinar: High-throughput MALDI TOF mass spectrometry for drug discoveryFIND OUT MORE
+ +